Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Attain enhances the power of purchase data across Amazon Ads DVA+ with direct audience integration
-
Metagenomi Therapeutics to Present Preclinical Data Supporting MGX-001, a Potential One-Time Therapy for Hemophilia A, in Oral Presentation at 68th American Society of Hematology Annual Meeting
-
SKYX Announces That, Based on Growing Winter Demand, It Will Launch 4 New Plug & Play Turbo Heater Fan Models in 5 Different Colors
-
Applied Biologics Announces Full Enrollment of BIOxHEAL™ Phase 3 Sentinel Safety Cohort
-
October 2026 WOW Supply Chain Activity Index Holds at 43.4 as Warehouse Space Tightens Heading Into Peak Season
-
MEGL Secures US$100 Million Dedicated Credit Facility to Accelerate Cross-Border Timber Trading
-
RedCloud to Participate in the 15th Annual ROTH Technology Conference
-
Autolus Therapeutics to Present Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2026
-
Immix Biopharma’s NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026
-
Cullinan Therapeutics Announces Presentations for CLN-049, a FLT3 T Cell Engager, and Velinotamig, a BCMA T Cell Engager, at the 68th ASH Annual Meeting
-
Superior Energy Services Announces $650 Million Senior Unsecured Notes Offering
-
Sensolus Supply Chain Velocity Index: 1 in 3 Industrial Assets Sat Still for an Entire Month
-
Aggreko Introduces New Line of Battery Energy Storage Systems for Immediate and Large-Scale Applications
-
Harsco Rail Executes Agreement to Exit Deutsche Bahn Engineered-to-Order Contract and Receives Initial Payment from Sale of Project Assets to GBM
-
Feedonomics Now Available in Amazon’s Shop Direct Merchant Workspace, Making it Easier for Brands to Get Their Products in Front of Amazon Customers
-
Report: 86% of Insurance Executives in Canada Believe AI Will Strengthen Customer Trust, Only 33% of Policyholders Agree
-
Hemab Therapeutics to Present Clinical and Preclinical Data from Multiple Blood Coagulation Programs at the 68th ASH Annual Meeting and Exposition
-
Doba Adds $20 Cash Bonus to Referral Program for Ecommerce Marketers
-
Daré Bioscience to Present at Stifel’s 2026 Healthcare Conference
-
SoundHound AI and Ultraviolette Announce Major Expansion of Agentic Voice AI Across Global Electric Vehicle Lineup
-
Disc Medicine Announces Multiple Presentations Across Portfolio at the 68th American Society of Hematology (ASH) Annual Meeting
-
Circana Launches Concept Testing and Forecasting Solutions to Help Brands Identify Winning Product Ideas and Predict Sales Potential
-
Tangram Announces Oral Presentation of TGM-148 Preclinical Data Highlighting Context-Dependent Mechanism of Action at the American Society of Hematology (ASH) 2026 Annual Meeting
-
Komodor Survey Finds More Than 50% of Engineering Organizations Face Control and Governance Issues as They Scale Agentic Operations
-
Formica Corporation Expands Design Possibilities with New Everform® Solid Surface and Homapal® Decors
-
Kura Oncology and Kyowa Kirin to Present First Ziftomenib-FLT3 Inhibitor Clinical Data at ASH 2026
-
Solu Therapeutics to Present Initial Phase 1 Results of STX-0712 and New Preclinical Data on STX-0640 in Two Oral Presentations at the 2026 ASH Annual Meeting
-
TestGrid Launches TestGrid ONE, the AI Operating System That Runs Quality Engineering
-
Lyell Immunopharma Announces $80 Million Private Placement to Advance Ronde-Cel Toward Planned BLA Submission
-
Northrop Grumman to Participate in the Baird 2026 Global Industrial Conference
-
CRISPR Therapeutics to Present Clinical Data from Zugo-cel in Large B-Cell Lymphoma at the 68th American Society of Hematology (ASH) Annual Meeting and Exposition
-
Agios to Highlight Strength and Differentiation of Rare Hematology Portfolio with New Clinical Data for Mitapivat in Sickle Cell Disease and AG-236 in Polycythemia Vera at ASH 2026
-
Secura Bio Announces Two Duvelisib Presentations on Peripheral T-Cell Lymphoma and Cutaneous T-Cell Lymphoma at the 2026 American Society of Hematology Annual Meeting
-
Corvus Pharmaceuticals Announces Initial Data from Soquelitinib Clinical Trial in Patients with Autoimmune Lymphoproliferative Syndrome (ALPS) will be Presented at the 68ᵗʰ American Society for Hem
-
Umoja Biopharma Announces Oral Presentation of First UB-VV400 In Vivo CAR T Cell Therapy Clinical Data and Four Total Presentations at the 68th ASH Annual Meeting
-
TranscendAP and Carahsoft Partner to Expand Access to AI-Powered AP Automation Across the Public Sector
-
Sophos Helps Organizations Secure the AI-Era Network as Demands on Performance and Protection Grow
-
Jack's Got Your Back: Jackery Kicks Off Black Friday Early with up to $3,230 Off Home Backup Power Solutions
-
Lyell Immunopharma to Present Positive Updated Ronde-Cel Data in More than 80 Patients at ASH 2026 from PiNACLE Pivotal Trial in 3L+ and from Phase 1/2 2L Cohort in Patients with Relapsed/Refractory L
-
Syndax to Host ASH Investor Event in Person and via Webcast on December 14, 2026
-
Phase 1 Data for CITY-FXI, an RNAi Therapeutic Candidate for Thromboembolic Diseases, Selected for Oral Presentation at the 68th ASH Annual Meeting
-
Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting
-
Atavistik Bio to Highlight Momentum Across Hematology Pipeline with Harmony-HHT Clinical Trial Update and New Preclinical Data from HHT and JAK2 V617F Programs at ASH 2026
-
New Study Finds Nearly Half of Women Seeking Help for Menstrual Symptoms Say Their Concerns Were Dismissed
-
Geron Corporation to Present Data Highlighting Clinical and Biological Activity of RYTELO® (imetelstat) at ASH 2026
-
SELLAS Life Sciences to Present Positive Phase 2 Data Demonstrating Encouraging Response and Survival Outcomes with SLS009 Combination in High-Risk AML at ASH 2026
-
Caribou Biosciences Announces Presentations at the 2026 American Society of Hematology (ASH) Annual Meeting
-
Descope Unveils Envoy, an Identity-Aware Way For Personal AI Agents to Act on People’s Behalf
-
Darwinium Wins Gold at 2026 AFR BOSS Most Innovative Companies Awards
-
Kamau Therapeutics Announces First Multi-Patient Clinical Data Showing Precise Correction of the Sickle Cell Mutation and Restoration of Adult Hemoglobin
